These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 7513981

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Urinary myelin basic protein-like material as a correlate of the progression of multiple sclerosis.
    Whitaker JN, Kachelhofer RD, Bradley EL, Burgard S, Layton BA, Reder AT, Morrison W, Zhao GJ, Paty DW.
    Ann Neurol; 1995 Oct; 38(4):625-32. PubMed ID: 7574459
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The presence of immunoreactive myelin basic protein peptide in urine of persons with multiple sclerosis.
    Whitaker JN.
    Ann Neurol; 1987 Nov; 22(5):648-55. PubMed ID: 2447826
    [Abstract] [Full Text] [Related]

  • 5. Measurement of immunoreactive myelin basic protein peptide (45-89) in cerebrospinal fluid.
    Gupta MK, Whitaker JN, Johnson C, Goren H.
    Ann Neurol; 1988 Mar; 23(3):274-80. PubMed ID: 2454068
    [Abstract] [Full Text] [Related]

  • 6. Relationship of urinary myelin basic protein-like material with cranial magnetic resonance imaging in advanced multiple sclerosis.
    Whitaker JN, Wolinsky JS, Narayana PA, Bartolucci AA, Noseworthy JH, Lublin FD, Linde A, Gjörstrup P, Sullivan HC, North American Linomide Investigators.
    Arch Neurol; 2001 Jan; 58(1):49-54. PubMed ID: 11176936
    [Abstract] [Full Text] [Related]

  • 7. Correlation of myelin basic protein-like material in cerebrospinal fluid of multiple sclerosis patients with their response to glucocorticoid treatment.
    Whitaker JN, Layton BA, Herman PK, Kachelhofer RD, Burgard S, Bartolucci AA.
    Ann Neurol; 1993 Jan; 33(1):10-7. PubMed ID: 7684211
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disorders.
    Whitaker JN, Lisak RP, Bashir RM, Fitch OH, Seyer JM, Krance R, Lawrence JA, Ch'ien LT, O'Sullivan P.
    Ann Neurol; 1980 Jan; 7(1):58-64. PubMed ID: 6153879
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Myelin basic protein in cerebrospinal fluid and other body fluids.
    Whitaker JN.
    Mult Scler; 1998 Feb; 4(1):16-21. PubMed ID: 9532587
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial.
    Bar-Or A, Vollmer T, Antel J, Arnold DL, Bodner CA, Campagnolo D, Gianettoni J, Jalili F, Kachuck N, Lapierre Y, Niino M, Oger J, Price M, Rhodes S, Robinson WH, Shi FD, Utz PJ, Valone F, Weiner L, Steinman L, Garren H.
    Arch Neurol; 2007 Oct; 64(10):1407-15. PubMed ID: 17698695
    [Abstract] [Full Text] [Related]

  • 16. Detection of myelin basic protein in cerebrospinal fluid.
    Ohta M, Ohta K.
    Expert Rev Mol Diagn; 2002 Nov; 2(6):627-33. PubMed ID: 12465458
    [Abstract] [Full Text] [Related]

  • 17. Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis.
    Garren H, Robinson WH, Krasulová E, Havrdová E, Nadj C, Selmaj K, Losy J, Nadj I, Radue EW, Kidd BA, Gianettoni J, Tersini K, Utz PJ, Valone F, Steinman L, BHT-3009 Study Group.
    Ann Neurol; 2008 May; 63(5):611-20. PubMed ID: 18481290
    [Abstract] [Full Text] [Related]

  • 18. A correlation between cerebrospinal fluid myelin basic protein and anti-myelin basic protein in multiple sclerosis patients.
    Warren KG, Catz I.
    Ann Neurol; 1987 Feb; 21(2):183-9. PubMed ID: 2435224
    [Abstract] [Full Text] [Related]

  • 19. Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis.
    Rieckmann P, Altenhofen B, Riegel A, Baudewig J, Felgenhauer K.
    Ann Neurol; 1997 Mar; 41(3):326-33. PubMed ID: 9066353
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.